Structures by: Budow S.
Total: 13
4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-6-methylsulfanyl-1H- pyrazolo[3,4-d]pyrimidine
C11H15N5O3S
Acta Crystallographica Section C (2005) 61, 9 o562-o564
a=9.4470(16)Å b=6.6805(9)Å c=10.6102(17)Å
α=90.00° β=98.563(9)° γ=90.00°
1-(2-deoxy-β-D-<i>erythro</i>-pentofuranosyl)-5-(prop-1-ynyl)-pyrimidin- 2,4(1<i>H</i>,3<i>H</i>)-dione
C12H14N2O5
Acta Crystallographica Section C (2009) 65, 12 o645-o648
a=5.6201(4)Å b=11.3645(9)Å c=19.0281(16)Å
α=90.00° β=96.659(4)° γ=90.00°
5-Ethynyl-2'-deoxycytidine
C11H13N3O4
Acta Crystallographica Section C (2012) 68, 10 o395-o398
a=7.8754(6)Å b=8.1504(6)Å c=10.0893(7)Å
α=108.637(3)° β=96.327(3)° γ=104.562(3)°
2'-Deoxy-7-propynyl-7-deazaadenosine
C14H16N4O3
Acta Crystallographica Section C (2006) 62, 5 o246-o248
a=6.5812(11)Å b=10.5084(13)Å c=19.216(2)Å
α=90.00° β=90.00° γ=90.00°
1,7-Dideaza-2'-deoxy-6-nitronebularine
C12H13N3O5
Acta Crystallographica Section C (2013) 69, 8 892-895
a=6.4621(4)Å b=9.1450(5)Å c=20.2969(12)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>^1^-(2'-deoxyribofuranoside) of 3-iodo-5-nitroindole
C13H13IN2O5
Acta Crystallographica Section C (2009) 65, 3 o100-o102
a=17.549(3)Å b=7.0981(10)Å c=10.9242(19)Å
α=90.00° β=90.00° γ=90.00°
2-amino-8-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)imidazo[1,2-<i>a</i>]- 1,3,5-triazin-4(8<i>H</i>)-one monohydrate
C10H12FN5O4,H2O
Acta Crystallographica Section C (2010) 66, 4 o194-o197
a=7.3752(6)Å b=6.3516(4)Å c=13.8654(11)Å
α=90.00° β=103.648(4)° γ=90.00°
2'-Deoxy-5-propynylcytidine
C12H15N3O4
Acta Crystallographica Section C (2007) 63, 1 o54-o57
a=8.3908(7)Å b=9.0698(8)Å c=9.7303(10)Å
α=64.734(5)° β=71.721(10)° γ=88.198(11)°
2'-deoxyimmunosine
C10H12N4O5S
Acta Crystallographica Section C (2007) 63, 9 o549-o551
a=5.2347(10)Å b=7.1855(13)Å c=8.9972(16)Å
α=110.756(12)° β=96.827(13)° γ=99.511(19)°
4-amino-2-(2-O-methyl-β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine monohydrate
C11H15N5O4,H2O
Acta Crystallographica Section C (2006) 62, 2 o79-o81
a=17.263(2)Å b=7.5673(7)Å c=10.4757(8)Å
α=90.00° β=93.128(8)° γ=90.00°
4-amino-5-fluoro-7-(β-D-ribofuranosyl)-7<i>H</i>- pyrrolo[2,3-<i>d</i>]pyrimidine
C11H13FN4O4
Acta Crystallographica Section C (2008) 64, 5 o293-o295
a=4.9394(13)Å b=14.6718(19)Å c=16.8181(16)Å
α=90.00° β=90.00° γ=90.00°
7-Amino-1-(2-deoxy-β-<i>erythro</i>-pentofuranosyl)-1<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidine
C9H12N6O3
Acta Crystallographica Section C (2010) 66, 11 o561-o564
a=7.1469(3)Å b=8.7025(4)Å c=9.1100(4)Å
α=90.00° β=104.056(2)° γ=90.00°
4-amino-1-(2-deoxy-β-D-<i>erythro</i>- pentofuranosyl)-5-[6-(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)hex-1- ynyl]pyrimidin-2(1<i>H</i>)-one
C24H28N6O4
Acta Crystallographica Section C (2012) 68, 4 o174-o178
a=12.525(6)Å b=15.051(7)Å c=12.719(6)Å
α=90.00° β=106.241(10)° γ=90.00°